c="Gly----Arg" 1:8 1:8||t="medication"||cui="C0017890"||tot="Glycine"||ns="-694"
c="elevated expression" 1:14 1:15||t="treatment"||cui="C0185117"||tot="Expression procedure"||ns="-861"
c="alpha-thalassemia" 1:18 1:18||t="problem"||cui="C0002312"||tot="alpha-Thalassemia"||ns="-1000"
c="beta chain alpha 2 beta 2 69" 2:8 2:14||t="medication"||cui="C1589399"||tot="Beta-2"||ns="-845"
c="Gly----Arg" 2:16 2:16||t="medication"||cui="C0017890"||tot="Glycine"||ns="-694"
c="electrophoretic mobilities" 2:34 2:35||t="problem"||cui="C0425245"||tot="Mobility as a finding"||ns="-827"
c="alpha-thalassemia" 2:53 2:53||t="problem"||cui="C0002312"||tot="alpha-Thalassemia"||ns="-1000"
c="microcytosis" 2:55 2:55||t="problem"||cui="C0221265"||tot="Microcytosis"||ns="-1000"
